| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.31 |
2e-09 |
| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
3e-08 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
5e-08 |
| mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.3 |
9e-08 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
ATRA |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
| mRNA |
BMS-536924 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-06 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-06 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
2e-05 |